Dr. Sachdev (Dev) Sidhu was recruited to the University of Toronto in 2008 after spending ten years as a Principal Investigator at Genentech, Inc., where he led the development of phage-displayed synthetic antibody libraries.
In 2010, Dev led the creation of the Toronto Recombinant Antibody Centre (TRAC), an integrated laboratory with a state-of-theart, high throughput antibody platform that can be applied to the generation of synthetic therapeutic-grade antibodies against virtually any protein. Through the TRAC, Dr. Sidhu has established more than 50 collaborations with researchers around the world.
Dev has founded several start up companies including Reflexion Pharmaceuticals, Northern Biologics, and Saksin Pharmaceuticals. He is on the Board of Directors for Bio-Techne and has previously served on the Boards for Adimab and Kolltan. Most recently, Dev was named the 2015 Christian B. Anfinsen Award winner from the Protein Society, recognizing significant technological advances in protein science.